Prevention, Treatment, Control and Sodium Reduction Policy
|
|
- Elisabeth Wiggins
- 5 years ago
- Views:
Transcription
1 Prevention, Treatment, Control and Sodium Reduction Policy Mary G. George MD, MSPH, Medical Officer Janelle Gunn MPH, RD, Policy Lead Division for Heart Disease and Stroke Prevention U.S. Department of Health and Human Services Centers for Disease Control and Prevention
2 Overview of this Module Hypertension and the impact on population health Assessment of hypertension Challenges in hypertension control JNC-VII treatment guidelines System-based initiatives to improve control Hypertension and sodium connection Community and population based changes to promote prevention
3 Discrepancy Between Health Determinants and Spending of $1.7 Trillion, 2007 Health Behaviors 50% Prevention 4% Environment 20% Medical Services 96% Genetics 20% Access to Care 10% Factors Influencing Health National Health Expenditures Source: Prevention Institute Reducing Healthcare Costs Through Prevention. Available at
4 EPIDEMIOLOGY
5
6 Hypertension Mortality Rates
7 The Magnitude of the Problem Hypertension is the single largest risk factor for cardiovascular disease mortality, accounting for 45% of all CVD deaths 1 INTERSTROKE Study concluded that hypertension provides 34.6% of the population-attributable risk (PAR) for stroke 2, while INTERHEART found it provides 17.9% of the PAR for myocardial infarction 3 The PAR is the reduction in incidence that would be observed if the population were entirely unexposed (did not have hypertension). 1. IOM (Institute of Medicine) A Population-Based Policy and Systems Change Approach to Prevent and Control Hypertension. 2. O Donnell MJ, Xavier D, Liu L et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case control study. The Lancet 2010; 376: Salim Yusuf, Steven Hawken, Stephanie Ôunpuu, Tony Dans, Alvaro Avezum, Fernando Lanas, Matthew McQueen, Andrzej Budaj, Prem Pais, John Varigos, Liu Lisheng, on behalf of the INTERHEART Study Investigators, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, The Lancet, 2004: 9438,
8 Comprehensive Approach to Hypertension Control Focused clinical interventions for those at high risk Lifestyle advice Population-based strategies
9 Stages of CVD Intervention Primordial Before risk factors develop Primary Treatment of risk factors Secondary After a CVD event occurs
10 Primordial Prevention Preventing Risk Factors from Developing In 1978, Strasser introduced the concept of primordial prevention. Once a risk factor has developed, it can be difficult to reduce the risk it contributes to overall health Medications and lifestyle interventions cannot reduce CVD event rates to levels seen in those who maintain optimal risk factor profiles (ideal cardiovascular health) into middle and older ages. Lloyd-Jones DM. Improving the cardiovascular health of the US population. JAMA. 12 ;
11 Population Strategy WHO, Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk., 2007
12 Major Shifts in Population Risks and Expanded Treatment, U.S. Ford, ES et.al. Explaining the decrease in U.S. deaths from coronary disease, NEJM 2007; 356: Change in numbers of deaths ,745 fewer deaths in Risk Factors worse: +17% Obesity (increase) +7% Diabetes (increase) +10% Risk Factors better: -65% Population BP fall -20% Smoking -12% Cholesterol (diet) -24% Physical activity -5% Treatments: -47% AMI treatments -10% Secondary prevention -11% Heart failure -9% Angina: CABG & PTCA -5% Hypertension therapies -7% Statins (primary prevention) -5%
13 What Can You Do to Make a Difference? Approximately 68 million U.S. adults (1 in 3) have hypertension Only 46% of adults with hypertension had adequately controlled blood pressure. The Million Hearts initiative has set a goal of 65% control by 2017 overall, and 70% in the clinical setting Valderrama A, et al. Million Hearts: Strategies to Reduce the Prevalence of Leading Cardiovascular Disease Risk Factors. MMWR. 2011; 60(36);
14 Patient Level Strategy A 10mmHg lower systolic blood pressure (SBP) or 5mmHg lower diastolic blood pressure (DBP) is associated with an approximately 20 25% lower risk of coronary heart disease (CHD) and an approximately 40% lower risk of stroke 1. Stamler J, Stamler R, Neaton JD, Blood pressure, systolic and diastolic, and cardiovascular risks. US population data, Arch Intern Med, 1993;153: Asia Pacific Cohort Studies Collaboration, Blood pressure and cardiovascular disease in the Asia Pacific region, J Hypertens, 2003;21: MacMahon S, Peto R, Cutler J, et al., Blood pressure, stroke and coronary heart disease. Part I, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias, Lancet, 1990;335:
15 JNC VII TREATMENT GUIDELINES
16 Assessment Assess for major cardiovascular risk factors Assess for identifiable causes of hypertension Sleep apnea Drug induced/related Renovascular disease Cushing s syndrome or steroid therapy Pheochromocytoma Coarctation of aorta Thyroid/parathyroid disease Chronic kidney disease Primary aldosteronism Greenland P ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary. JACC. Vol. 56, No. 25, 2010.
17 Lifestyle interventions JNC VII recommends therapeutic lifestyle change only for most people with pre-hypertension Weight reduction DASH diet Dietary sodium reduction Physical Activity Moderate alcohol consumption
18 JNC VII Medication Recommendations* Pre-hypertension Lifestyle interventions Stage 1 Hypertension (SBP or DBP mmhg) Thiazide-type diuretics for most. May consider ACEI, ARB, BB, CCB, or combination Stage 2 Hypertension (SBP 160 or DBP 100 mmhg) 2-drug combination for most (usually thiazide-type diuretic* and ACEI, or ARB, or BB, or CCB) ACEI ARB BB CCB = ace inhibitors = angiotensin receptor blockers = beta blockers = calcium channel blockers *JNC-VII includes chlorthalidone among thiazide-type diuretics.
19 Medication Adherence Clinician empathy increases patient trust and motivation Physicians should consider their patients cultural beliefs and individual attitudes in formulating therapy Team-based care (pharmacy medication therapy management, physician assistants, nurse practitioners, etc.) Consider the Morisky Medication Adherence questionnaire for your hypertensive patients
20 CHALLENGES IN HYPERTENSION CONTROL
21 Special Populations Minorities Blacks have an increased rate of conversion from prehypertension to hypertension Median age-adjusted conversion time when 50% of patients converted from pre-hypertension to hypertension was 2.7 years in whites and 1.7 years in blacks Over age 80 Significant benefits from treatment May be more sensitive to medication side effects or drug interactions due to an increased number of medications taken Selassie A, et al. Progression is accelerated from prehypertension to hypertension in blacks. Hypertension. 2011; 58:
22 Resistant Hypertension Hypertension not controlled using a combination of 3 antihypertensive drug classes, including a diuretic Non-compliance/adherence with medication Fluid imbalance renal failure Hormonal imbalance
23 Incidence of Resistant Hypertension Study from Colorado Kaiser Permanente, found that 1.9% of patients (1 in every 50 patients) with incident hypertension who were begun on treatment developed resistant hypertension within a median of 1.5 years from initial treatment They found 16% of patients on 3 or more drugs continued to have resistant hypertension Daugherty SL, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation. February 29, Epub ahead of print]
24 What Happens if Hypertension isn t Controlled? Left ventricular hypertrophy (LVH) Heart failure Chronic kidney failure Stroke (cerebral hemorrhage) Vascular dementia Retinopathy
25 Incidence of ESRD by Systolic Blood Pressure: Multiple Risk Factor Intervention Trial * Incidence of ESRD per 100,000 Person-Years 5.4 White Men (n = 300,645) Black Men (n = 20,222) < >140 Systolic Blood Pressure (mm Hg) * The original cohort of 332,544 men included 11,677 men in other ethnic groups whose data are excluded from this comparison. ESRD = end-stage renal disease Klag MJ, et al. End-stage renal disease in African-American and white men. 16-year MRFIT findings. JAMA. 1997;277: Slide Source Hypertension Online org
26 Effects of Systolic and Diastolic Blood Pressures on CHD Mortality: MRFIT * CHD Death Rate Per 10,000 Person-Years Diastolic Blood Pressure (mm Hg) * Data shown only for 316,099 white men 35 to 57 years of age who were followed for a mean of 12 years. CHD = coronary heart disease MRFIT = Multiple Risk Factor Intervention Trial 8.8 Neaton JD, et al. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992;152: < < Systolic Blood Pressure (mm Hg)
27 Risk of Stroke Death According to Blood Pressure (mm Hg): MRFIT Relative Risk of Stroke Death Systolic Blood Pressure (SBP) Diastolic Blood Pressure (DBP) * * * * * SBP DBP < < Decile (Lowest 10%) (Highest 10%) MRFIT = Multiple Risk Factor Intervention Trial; *P < 0.01; P < Stamler J, et al. Arch Intern Med. 1993;153: ; He J, Whelton PK. Am Heart J. 1999;138(Pt 2): Slide Source Hypertension Online org
28 SYSTEM-BASED INITIATIVES TO IMPROVE CONTROL
29 Meaningful Use and Pay-for-Performance PQRS Measure #317: Preventive Care and Screening: Screening for High Blood Pressure Percentage of patients aged 18 and older who are screened for high blood pressure. PQRS Measure #236 (NQF 0018): Hypertension: Controlling High Blood Pressure Percentage of patients aged 18 through 85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/<90) during the measurement year.
30 Team-based care the Role of the Pharmacist The Asheville Project is a community-based, pharmacistdirected, medication therapy management (MTM) program provided for several employers in the Asheville, NC area Patients with hypertension receiving education and longterm medication therapy management services achieved significant clinical improvements that were sustained for as long as 6 years cardiovascular events adherence to medications Bunting BA, et al. The Asheville Project: Clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia. J Am Pharm Assoc. 2008;48:23 31.
31 Quality Improvement and Clinical Decision Support A proven concept that improves care! Alerts Reminders Reports Templates for management Built-in access to guidelines Enhances implementation of quality improvement initiatives
32 Clinical-Community Reporting Efforts RWJF Aligning Forces for Quality Public reporting Wisconsin Collaborative for Healthcare Quality
33 The Connection HYPERTENSION AND SODIUM
34 The Effect of Sodium Intake on Blood Pressure Sodium intake is one of several dietary factors that increases blood pressure Sodium is the principal cation of the extracellular fluid and functions as the osmotic determinant in regulating extracellular fluid volume and plasma volume Sodium is stored in the blood and in the fluid surrounding the cells; kidneys control the body sodium concentration by clearing excess sodium through urine
35 The Effect of Sodium Intake on Blood Pressure Sodium affects blood pressure by changing blood volume Absorbed sodium remains in the extracellular compartments, including plasma (at [140 mmol/l]; interstitial fluid [145 mmol/l]; plasma water [150 mmol/l]; muscle tissue [3 mmol/l]) These levels maintain blood pressure in the normal range Increased sodium intake =increased blood volume = higher blood pressure Sodium reduction = decreased blood volume = lower blood pressure Institute of Medicine. Dietary reference intakes for water, potassium, sodium chloride, and sulfate. Washington, DC: National Academies Press; 2004.
36 Excess Sodium Intake Leads to Hypertension Sodium, through hypertension, is a major contributor to death, disability, disparities, and costs attributable to cardiovascular diseases (CVD) Economic burden Treatment for heart disease, stroke, and other CVD accounts for 1 in 6 U.S. health dollars spent ($273 billion in 2008) Globally, 8.5 million deaths could be averted over 10 years from 2006 to 2015 through a 15% reduction in sodium intake Vital Signs: MMWR 2011; 60(4):1-3 8 Heidenreich PA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011;123; Asaria P, et al. Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use. Lancet 2007;370:
37 Sodium Reduction Benefits All Ranges of Blood Pressure Evidence supports a strong, direct relationship between blood pressure and vascular mortality No evidence of a blood pressure threshold vascular mortality increases throughout the range of blood pressures in both nonhypertensive and hypertensive individuals Average blood pressure was reduced by 22.7/9.1 mm Hg in patients with resistant hypertension when switched from a high to low sodium diet In most individuals blood pressure is reduced within days to weeks of reducing sodium intake Institute of Medicine. Dietary reference intakes for water, potassium, sodium chloride, and sulfate. Washington, DC: National Academies Press; Pimenta E, Gaddam KK, Oparil S, Aban I, Husain S, Dell'Italia J, Calhoun DA. Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial. Hypertension. 2009; 54:
38 DASH and DASH Sodium Trials Dietary Approaches to Stop Hypertension (DASH) Trial Compared the effects of three diets typical American diet, fruits and vegetable diet, and a diet rich in fruits and vegetables and low fat dairy, and reduced in saturated fat, total fat, and cholesterol All diets provided ~ 3,000 mg sodium per day Combination diet (DASH) produced the largest blood pressure reduction after 8 weeks average of 5.5 / 3.0 mm Hg Participants with hypertension experienced an average blood pressure of 11.4 / 5.5 mm Hg DASH Sodium Trial DASH diet and three levels of sodium intake 1,150 mg, 2,300 mg, and 3,450 mg DASH diet and a low level of sodium SBP by 7.1 mg Hg Participants with HTN experienced a BP of 11.5 mm Hg Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997;336: ; Sacks et al. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet. N Engl J Med 2001; 344:3-10
39 Sodium Intake Levels: Recommended and Actual Recommended levels of sodium intake 2010 Dietary Guidelines for Americans Reduce sodium to < 2300 mg/day For specific populations: 1,500 mg/day 51 years old African Americans Have high blood pressure, diabetes, or chronic kidney disease About half the U.S. population and the majority of adults Actual sodium intake Average daily sodium intake for U.S. adults is >3,300 mg/day USDA and HHS. Dietary Guidelines for Americans, th edition. Washington, DC: Government Printing Office; Vital Signs: MMWR 2012; 61(Early Release);1-7
40 Individual Sodium Reduction Has Population Benefits Reducing the sodium content by 25% of the top 10 food category contributors to sodium intake could result in a 360 mg reduction in average sodium consumption in the United States Reducing average population sodium consumption by 400 mg has been projected to avert up to 28,000 deaths from any cause and save $7 billion in healthcare expenditures annually CDC, MMWR;2012;61:1-7. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med 2010;362:590 9.
41 Reducing Sodium Intake Reduces Blood Pressure Reducing average population sodium intake to 1,500 mg/day may Reduce cases of hypertension by 16 million Save $26 billion health care dollars Gain 459,000 Quality Adjusted Life Years (QALYs) Even reducing sodium intake to 2,300 mg/day could Reduce cases of hypertension by 11 million Save $18 billion health care dollars Gain 312,000 QALYs Sacks FM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Eng J Med 2001;344:3 10. Palar K, et al. Potential societal savings from reduced sodium consumption in the U.S. adult population. Am J Health Promot 2009;24(1):49 57.
42 Percent of US persons exceeding their 2010 Dietary Guidelines for Americans sodium intake recommendations* % Age Group *All people age 51 and older should reduce sodium intake to 1,500 mg/day. MMWR 2011;60:
43 Most of the sodium we eat comes from processed and restaurant foods Mattes RD, et al. Relative contributions of dietary sodium sources. J AM Coll Nutr 1991;10:
44 44% of US sodium intake comes from ten types of foods Rank Food Types % 1 Bread and rolls Cold cuts and cured meats Pizza Poultry Soups Sandwiches Cheese Pasta mixed dishes Meat mixed dishes Savory snacks 3.1 CDC, MMWR;2012;61:1-7.
45 Other Guidelines and Recommendations Institute of Medicine Reduce the sodium content of the U.S. food supply Health practitioners: commitment to incorporate guidelines on sodium intake into prevention messages and standards of care Million Hearts Reduce population sodium intake by 20% by January 1, 2017 Healthy People 2020 Reduce mean U.S. population sodium intake to 2,300 mg per day by 2020 American Heart Association Reduce population sodium intake to 1500 mg per day
46 Other Guidelines and Recommendations American Medical Association Stepwise, minimum 50% reduction in sodium in processed foods, fast-food products, and restaurant meals over the next decade Physicians and other clinicians should educate patients about the benefits of long-term, moderate reductions in sodium intake Substantial public health benefits accrue from small reductions in population blood pressure distribution, achievable with long-term modest reduction in sodium intake AMA supports the National Salt Reduction Initiative Aim is to lower U.S. population sodium intake by 20% over five years through sodium reduction in packaged, processed and restaurant foods by 25% over that time period Dickinson B, Havas S. Reducing the Population Burden of Cardiovascular Disease by Reducing Sodium Intake A Report of the Council on Science and Public Health. Arch Intern Med. 2007;167(14):
47 Adults with Self-Reported Hypertension Who Received and Acted on Low-Salt Advice Age, years 50% Advice and behavioral change Behavioral Risk Factor Surveillance System, 19 states, 1 territory, and Washington, DC, 2007
48 Role of the Provider AMA recommends that health care providers educate patients on how to reduce sodium intake However, nearly 70% of primary health care providers report advising their patients to remove the salt shaker from the table, and the majority reported advising patients to add less salt during cooking, even though these behaviors are unlikely to result in major sodium reduction Havas S, Dickinson BD, Wilson M. The urgent need to reduce sodium consumption. JAMA. 2007;298: Fang J, Cogswell M, Keenan N, Merritt R. Primary Health Care Providers' Attitudes and Counseling Behaviors Related to Dietary Sodium Reduction. Archives of Internal Medicine 2012;172(1): doi: /archinternmed Image adapted from CDC Vital Signs Fact Sheet, Where s the Sodium
49 Health Care Providers Who Agree with Importance of Sodium Reduction for their Patients Statement: Most of my patients should reduce their sodium intake Health care provider Fang J, Cogswell M, Keenan N, Merritt R. Primary Health Care Providers' Attitudes and Counseling Behaviors Related to Dietary Sodium Reduction. Archives of Internal Medicine 2012;172(1): doi: / archinternmed
50 Role of the Provider Patients may be able to lower the required dose of blood pressure medicines through reduced sodium intake Patients with normotension or prehypertension may reduce or prolong their risk for developing hypertension through sodium reduction Referral to a Registered Dietitian for Counseling Education during BP screenings Downloadable CDC resource: Reducing Sodium in Your Diet to Help Control Your Blood Pressure Advise consumption of fresh fruits and vegetables, frozen fruits and vegetables without sauce, and no salt added canned vegetables Advise limiting processed foods high in sodium
51 Role of the Provider Current food environment makes it difficult for consumers who want or need to consumes less sodium to do so Reduction of sodium in the food supply, coupled with consumer education and knowledgeable use of food labels, may provide greater choice and control over sodium intake, a modifiable risk factor for high blood pressure, heart disease, and stroke
52 Patient Education It s Not the Salt Shaker, It s the Food Choices!
53 COMMUNITY AND POPULATION-BASED CHANGES TO PROMOTE PREVENTION
54 Community Partners Community health workers and Promotores de Salud A liaison between health and social services and the community facilitating access to care Provides a trusted liaison through a shared culture with the people they serve Barbershop- and beauty shop-based interventions to improve hypertension control Faith-based support programs Ferdinand KC, et al. Community-based approaches to prevention and management of hypertension and cardiovascular disease. Journal of Clinical Hypertension Online ahead of print. DOI: /j x
55 Population-Based Strategy SBP Distributions After Intervention Before Intervention Reduction in BP Stambler.Hypertension. 1991; Reductions in SBP % Reduction in Mortality Stroke CHD Total
56 CDC Efforts Related to Hypertension Control Community Transformation Grants Sodium Reduction in Communities WISEWOMAN program State Health Departments Million Hearts Initiative
57 Public Health Public health approaches such as increasing physical activity and reducing trans-fats and salt in processed foods can achieve a downward shift in the distribution of a population s blood pressure. In addition to CDC activities on the previous slide, CDC funds many other programs to promote healthy lifestyles.
58 Quick Facts about Hypertension and Sodium 9 in 10 people eat too much sodium 44% of the sodium we eat comes from 10 types of foods Reducing sodium by 1,200 mg/day can save $20 B Image adapted from CDC Vital Signs Fact Sheet, Where s the Sodium Image adapted from CDC Vital Signs Fact Sheet, High Blood Pressure and Cholesterol Every 39 seconds an adult dies of heart attack, stroke, or other cardiovascular disease Nearly 1 in 2 people with hypertension doesn't have it under control
59 Hypertension Control and Sodium Reduction EDUCATOR TOOLKIT
60 Resources CDC Vital Signs: Hypertension and Cholesterol ndex.html CDC Vital Signs: Where s the Sodium? CDC Vital Signs: Prevalence, Treatment, and Control of Hypertension 04a4.htm?s_cid=mm6004a4_w
61 Resources CDC Grand Rounds: Sodium Reduction: Time for Choice CDC Blood Pressure Information DASH Diet h/new_dash.pdf
62 Resources JNC VII The Asheville Project Morisky Medication Adherence Questionnaire %2C%20Ang%20A%2C%20Krousel- Wood%20M%2C%20Ward%20H.%20Predictive%20Validity% 20of%20a%20Medication%20Adherence
63 Important Hypertension Trials SHEP (Systolic Hypertension in the Elderly Program) In persons aged 60 years and over with isolated systolic hypertension, antihypertensive stepped-care drug treatment with low-dose chlorthalidone as step 1 medication reduced the incidence of total stroke by 36% ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) The mean systolic blood pressure was 4mm Hg higher in blacks and 2 mm Hg higher in non-blacks in the lisinopril group than in the chlorthalidone group. Blood pressure control was 8-13% better in the chlorthalidone group than in the lisinopril group for blacks. Although in the trial overall the chlorthalidone group was better controlled than the lisinopril group, this difference between the two groups among blacks is quite striking. MRFIT (Multiple Risk Factor Intervention Trial) Changed protocol in clinics using primarily HCTZ to chlorthalidone due in part to an a higher trend in mortality in clinics using predominantly hydrochlorothiazide. Changing to chlorthalidone was associated with a trend toward better outcomes. TROPHY (Trial of Preventing Hypertension) Found that it is possible to prevent or delay the onset of clinical hypertension in people with blood pressure that falls within the "prehypertension" category
64 Important Hypertension Trials TOHP (Trials of Hypertension Prevention) Sodium reduction, previously shown to lower blood pressure, may also reduce long term risk of cardiovascular events. TONE (Trial of Nonpharmacologic Interventions in the Elderly) Reduced sodium intake and weight loss constitute a feasible, effective, and safe nonpharmacologic therapy of hypertension in older persons. HYVET (Hypertension in the Very Elderly Trial) According to Timothy Gardner, M.D., President of the American Heart Association: The results of HYVET demonstrate that effective antihypertensive treatment with indapamide (Natrilix SR) in persons aged 80 years old or older, is beneficial in reducing the risk of cardiovascular events, and thus extends the patient group in whom prevention must be pursued.
65 From Medscape Education Case Studies Timing is Everything: 24-Hour Control of Blood Pressure William C. Cushman, MD
66 How well prepared are your residents for managing hypertension? Study from Johns Hopkins of baseline knowledge of PGY3 internal medicine residents Hypertension 62-66% Lipid Management 31-36% Diabetes 35-40% Smoking 53-54% Obesity 44-47% Total of 15 Chronic Diseases 48-50% Baseline knowledge of PGY3 did not differ from PGY1 and PGY2 Sisson SD, Dalal D. Internal Medicine residency training on topics in ambulatory care: A status report. Am Jour of Medicine. 2011;124(1):86-90.
67 Discussion Questions (could be used before delivering the module or after) You have a busy Family Medicine Practice 1. At what point would you consider referring a patient for hypertension control? 2. How does team-based care delivery for hypertension control work in your clinic? 3. Can you think of ways to improve your health information technology to improve hypertension control? 4. How do you guide your patients to reduce sodium in their diet?
Current CDC Efforts Concerning Sodium Intake
Current CDC Efforts Concerning Sodium Intake Robert K. Merritt Chief & Supervisory Health Scientist Epidemiology & Surveillance Branch Division for Heart Disease and Stroke Prevention National Center for
More informationWebinar #4: Uncontrolled Hypertension: Data, Surveillance and Opportunities. Toll free: Participant code:
Webinar #4: Uncontrolled Hypertension: Data, Surveillance and Opportunities Toll free: 1-877-989-1344 Participant code: 1488488 National Center for Chronic Disease Prevention and Health Promotion Division
More informationClinical and Public Health Progress Each Contributed About Half to the 50% Reduction in Heart Disease Deaths, US,
The Beat Goes On Kim La Croix, MPH, RD Nutrition Coordinator/Public Health Nutritionist Public Health Division Center for Prevention & Health Promotion Health Promotion Chronic Disease Prevention Objectives
More informationHypertension Management Controversies in the Elderly Patient
Hypertension Management Controversies in the Elderly Patient Juan Bowen, MD Geriatric Update for the Primary Care Provider November 17, 2016 2016 MFMER slide-1 Disclosure No financial relationships No
More informationUsing the New Hypertension Guidelines
Using the New Hypertension Guidelines Kamal Henderson, MD Department of Cardiology, Preventive Medicine, University of North Carolina School of Medicine Kotchen TA. Historical trends and milestones in
More informationNew Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets
New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets Sidney C. Smith, Jr. MD, FACC, FAHA Professor of Medicine/Cardiology University of
More informationWhat s In the New Hypertension Guidelines?
American College of Physicians Ohio/Air Force Chapters 2018 Scientific Meeting Columbus, OH October 5, 2018 What s In the New Hypertension Guidelines? Max C. Reif, MD, FACP Objectives: At the end of the
More informationHypertension Update. Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy
Hypertension Update Sarah J. Payne, MS, PharmD, BCPS Assistant Professor, Department of Pharmacotherapy UNT System College of Pharmacy Introduction 1/3 of US adults have HTN More prevalent in non-hispanic
More informationPrevention of Heart Failure: What s New with Hypertension
Prevention of Heart Failure: What s New with Hypertension Ali AlMasood Prince Sultan Cardiac Center Riyadh 3ed Saudi Heart Failure conference, Jeddah, 13 December 2014 Background 20-30% of Saudi adults
More informationVA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005
VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005 1 Any adult in the health care system 2 Obtain blood pressure (BP) (Reliable,
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationDISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.
JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES Tiffany Dickey, PharmD Assistant Professor, UAMS COP Clinical Pharmacy Specialist, Mercy Hospital Northwest AR DISCLOSURE I
More informationHypertension: JNC-7. Southern California University of Health Sciences Physician Assistant Program
Hypertension: JNC-7 Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! Reference Card
More informationHypertension Update Clinical Controversies Regarding Age and Race
Hypertension Update Clinical Controversies Regarding Age and Race Allison Helmer, PharmD, BCACP Assistant Clinical Professor Auburn University Harrison School of Pharmacy July 22, 2017 DISCLOSURE/CONFLICT
More informationmajor public health burden
HYPERTENSION INTRODUCTION Hypertension is one of the major public health burden in the recent times. Hypertension remains a challenging medical condition among the noncommunicable diseases of ever growing
More information2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.
2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension Writing Group: Background Hypertension worldwide causes 7.1 million premature
More informationJNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults
JNC 8 2014 Evidence-Based Guidelines for the Management of High Blood Pressure in Adults Table of Contents Why Do We Treat Hypertension? Blood Pressure Treatment Goals Initial Therapy Strength of Recommendation
More informationDiversity and HTN: Approaches to optimal BP control in AfricanAmericans
Diversity and HTN: Approaches to optimal BP control in AfricanAmericans Quinn Capers, IV, MD, FACC, FSCAI Assistant Professor of Medicine Associate Dean for Admissions Do Racial Differences Really Exist
More informationBlood Pressure Acre Surgery Diviash Thakrar
Blood Pressure Acre Surgery Diviash Thakrar Why Are We Doing This? 1. Improve education for patients within the practice 2. Allow us use this for general health promotion Raise money for charity 3. Raise
More informationHealth Benefits of Lowering Sodium Intake in the US
Health Benefits of Lowering Sodium Intake in the US Lawrence J Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Director, Welch Center for Prevention, Epidemiology
More informationMANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION
Management of Hypertension: Treatment Thresholds and Medication Selection Robert B. Baron, MD MS Professor and Associate Dean Declaration of full disclosure: No conflict of interest Presentation Goals
More informationObjectives. Describe results and implications of recent landmark hypertension trials
Hypertension Update Daniel Schwartz, MD Assistant Professor of Medicine Associate Medical Director of Heart Transplantation Temple University School of Medicine Disclosures I currently have no relationships
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationUpdate in Hypertension
Update in Hypertension Eliseo J. PérezP rez-stable MD Professor of Medicine DGIM, Department of Medicine UCSF 20 May 2008 Declaration of full disclosure: No conflict of interest (I have never been funded
More informationPreventing and Treating High Blood Pressure
Preventing and Treating High Blood Pressure: Finding the Right Balance of Integrative and Pharmacologic Approaches Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Blood Pressure
More informationHYPERTENSION GUIDELINES WHERE ARE WE IN 2014
HYPERTENSION GUIDELINES WHERE ARE WE IN 2014 Donald J. DiPette MD FACP Special Assistant to the Provost for Health Affairs Distinguished Health Sciences Professor University of South Carolina University
More informationLong-Term Care Updates
Long-Term Care Updates August 2015 By Darren Hein, PharmD Hypertension is a clinical condition in which the force of blood pushing on the arteries is higher than normal. This increases the risk for heart
More informationHypertension Update Background
Hypertension Update Background Overview Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Management Guideline Comparison
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationClinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital
Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8 Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital Objectives Review the Eighth Joint National Committee (JNC
More informationWhat is hypertension?
HYPERTENSION What is hypertension? Abnormally elevated arterial blood pressure that is usually indicated by an adult systolic blood pressure of 140 mm Hg or greater or a diastolic blood pressure of 90
More informationHypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)
Practice Guidelines and Principles: Guidelines and principles are intended to be flexible. They serve as reference points or recommendations, not rigid criteria. Guidelines and principles should be followed
More informationFor instance, it can harden the arteries, decreasing the flow of blood and oxygen to the heart. This reduced flow can cause
High Blood Pressure Blood pressure is the force of blood against your artery walls as it circulates through your body. Blood pressure normally rises and falls throughout the day, but it can cause health
More informationHypertension Update. Aaron J. Friedberg, MD
Hypertension Update Aaron J. Friedberg, MD Assistant Professor, Clinical Division of General Internal Medicine The Ohio State University Wexner Medical Center Background Diagnosis Management Overview Guideline
More informationHypertension JNC 8 (2014)
Hypertension JNC 8 (2014) Renewed: February 2018 Updated: February 2015 Comparison of Seventh Joint National Committee (JNC 7) vs. Eighth Joint National Committee (JNC 8) Hypertension Guidelines Methodology
More informationNew Hypertension Guideline Recommendations for Adults July 7, :45-9:30am
Advances in Cardiovascular Disease 30 th Annual Convention and Reunion UERM-CMAA, Inc. Annual Convention and Scientific Meeting July 5-8, 2018 New Hypertension Guideline Recommendations for Adults July
More informationHypertension in the Elderly. John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care
Hypertension in the Elderly John Puxty Division of Geriatrics Center for Studies in Aging and Health, Providence Care Learning Objectives Review evidence for treatment of hypertension in elderly Consider
More informationHypertension in 2015: SPRINT-ing ahead of JNC-8. MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic
Hypertension in 2015: SPRINT-ing ahead of JNC-8 MAJ Charles Magee, MD MPH FACP Director, WRNMMC Hypertension Clinic Conflits of interest? None Disclaimer The opinions contained herein are not to be considered
More informationA Needs Assessment of Hypertension in Georgia
A Needs Assessment of Hypertension in Georgia Faye Lopez Mercer University School of Medicine Marylen Rimando Mercer University School of Medicine Harshali Khapekar Mercer University School of Medicine
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationHYPERTENSION: ARE WE GOING TOO LOW?
HYPERTENSION: ARE WE GOING TOO LOW? George L. Bakris, M.D.,F.A.S.N.,F.A.S.H., F.A.H.A. Professor of Medicine Director, ASH Comprehensive Hypertension Center University of Chicago Medicine Chicago, IL USA
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationModern Management of Hypertension
Modern Management of Hypertension Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Hypertension Prevalence
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationObjectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence
JNC 7 Is Nice But What s Up With JNC 8? 37 th Annual CAPA Conference October 4 th 2013 Ignacio de Artola, Jr. M.D. Assistant Professor of Clinical Family Medicine Medical Director, Primary Care Physician
More informationNew Lipid Guidelines. PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids.
PREVENTION OF CARDIOVASCULAR DISEASE IN WOMEN: Implications of the New Guidelines for Hypertension and Lipids Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine Disclosure No relevant
More informationWhy you should take the latest sodium study with a huge grain of salt
Harvard School of Public Health The Nutrition Source Flawed Science on Sodium from JAMA Why you should take the latest sodium study with a huge grain of salt A new study would have you believe that low-salt
More informationThe prevalence of hypertension in a representative
CLINICAL STRATEGIES FOR OPTIMAL HYPERTENSION MANAGEMENT Roger S. Blumenthal, MD * ABSTRACT In the United States, approximately 25% of the adult population older than 40 years has hypertension. Americans
More information5.2 Key priorities for implementation
5.2 Key priorities for implementation From the full set of recommendations, the GDG selected ten key priorities for implementation. The criteria used for selecting these recommendations are listed in detail
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationYounger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.
Appendix 2A - Guidance on Management of Hypertension Measurement of blood pressure All adults from 40 years should have blood pressure measured as part of opportunistic cardiovascular risk assessment.
More informationHypertension awareness, treatment, and control
O r i g i n a l P a p e r Prevalence of Self-Reported High Blood Pressure Awareness, Advice Received From Health Professionals, and Actions Taken to Reduce High Blood Pressure Among US Adults Healthstyles
More informationALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic
1 U.S. Department of Health and Human Services National Institutes of Health Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker
More information7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension
Prevalence of Hypertension Hypertension: Diagnosis and Management T. Villela, M.D. Program Director University of California, San Francisco-San Francisco General Hospital Family and Community Medicine
More information7/6/2012. University Pharmacy 5254 Anthony Wayne Drive Detroit, MI (313)
University Pharmacy 5254 Anthony Wayne Drive Detroit, MI 48202 (313) 831-2008 Be able to identify the signs of a heart attack or stoke Identify what puts you at a higher risk for cardiovascular disease,
More informationTIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**
Documentation and coding guide Disease definitions* HTN is diagnosed when the average of two or more (systolic of diastolic) blood pressure readings are found to be elevated on two or more office visits
More informationFive chapters 1. What is CVD prevention 2. Why is CVD prevention needed 3. Who needs CVD prevention 4. How is CVD prevention applied 5. Where should CVD prevention be offered Shorter, more adapted to clinical
More informationManagement of Hypertension. Ahmed El Hawary MD Suez Canal University
Management of Hypertension Ahmed El Hawary MD Suez Canal University Minimal vs. Optimal Care Resources more than science affect type of care and level of management. what is possible (minimal care) and
More informationEvolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)
Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH) Sidney C. Smith, Jr. MD, FACC, FAHA, FESC Professor of Medicine/Cardiology University of North Carolina
More informationJNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH
JNC 8 -Controversies Sagren Naidoo Nephrologist CMJAH Joint National Committee (JNC) Panel appointed by the National Heart, Lung, and Blood Institute (NHLBI) First guidelines (JNC-1) published in 1977
More information2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST
CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES George L. Bakris, M.D.,F.A.S.N., F.A.H.A. Professor of Medicine Director, Am Heart Assoc. Comprehensive Hypertension Center University of Chicago Medicine
More informationModern Management of Hypertension: Where Do We Draw the Line?
Modern Management of Hypertension: Where Do We Draw the Line? Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Blood Pressure
More informationManaging Hypertension in 2016
Managing Hypertension in 2016: Where Do We Draw the Line? Disclosure No relevant financial relationships Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine baron@medicine.ucsf.edu
More informationEgyptian Hypertension Guidelines
Egyptian Hypertension Guidelines 2014 Egyptian Hypertension Guidelines Dalia R. ElRemissy, MD Lecturer of Cardiovascular Medicine Cairo University Why Egyptian Guidelines? Guidelines developed for rich
More informationHypertension. Most important public health problem in developed countries
Hypertension Strategy for Continued Success in Treatment for the 21st Century November 15, 2005 Arnold B. Meshkov, M.D. Associate Professor of Medicine Temple University School of Medicine Philadelphia,
More informationSodium and Health: Evidence, Policy, Reality
Sodium and Health: Evidence, Policy, Reality Cheryl A. M. Anderson, PhD, MPH, MS University of California San Diego Department of Family Medicine and Public Health Email: c1anderson@ucsd.edu Sodium Intake
More informationHypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, Financial Disclosures
Hypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, 2015 William C. Cushman, MD Professor, Preventive Medicine, Medicine, and Physiology University
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationRole of Minerals in Hypertension
Role of Minerals in Hypertension Lecture objectives By the end of the lecture students will be able to Define primary and secondary hypertention and their risk factors. Relate role of minerals with hypertention.
More informationSodium Reduction: A Public Health Imperative
Sodium Reduction: A Public Health Imperative Darwin R. Labart he, MD, MPH, PhD Director, Division for Heart Disease and Stroke Prevention National Center for Chronic Disease Prevention and Health Promotion
More informationDisclosures. Hypertension: Nationwide Dilemma. Learning Objectives. What s Currently Recommended? Specific Concerns 3/9/2012
How Should We ACCOMPLISH Good Blood Pressure Control In Our VETS? Disclosures No conflicts of interest to disclose Updates in the Management of HypertensionIn the Elderly Antoine T. Jenkins, Pharm.D.,
More informationManagement of Hypertension. M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine
Management of Hypertension M Misra MD MRCP (UK) Division of Nephrology University of Missouri School of Medicine Disturbing Trends in Hypertension HTN awareness, treatment and control rates are decreasing
More informationShould We Put the Salt Shaker Down?
Should We Put the Salt Shaker Down? How Much is Too Much? New Sodium Recommendations Barbara Fletcher, RN, MN, FAHA, FPCNA, FAAN Clinical Associate Professor Brooks College of Health School of Nursing
More informationTodd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM
Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM Faculty Disclosure I have no financial interest to disclose No off-label use of medications will be discussed FIFTH ANNUAL SYMPOSIUM Recognize changes between
More informationISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW
ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):
More informationManagement of Hypertension in Women
Management of Hypertension in Women Eliseo J. Pérez-Stable MD Professor of Medicine DGIM, Department of Medicine July 1, 2013 Declaration of full disclosure: No conflict of interest (I have never been
More informationBlood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension
525 Blood Pressure Lowering Efficacy of Perindopril/ Indapamide Fixed Dose Combination in Uncontrolled Hypertension PHIMDA Kriangsak 1* and CHOTNOPARATPAT Paiboon 2 1 Diabetes and Hypertension Clinic,
More informationHypertension (JNC-8)
Hypertension (JNC-8) Southern California University of Health Sciences Physician Assistant Program Management and Treatment of Hypertension April 17, 2018, presented by Ezra Levy, Pharm.D.! The 8 th Joint
More informationTreating Hypertension from
Treating Hypertension from Initiation to Resistance: A Case Study Approach Michelle Krause, MD Division of Nephrology University of Arkansas for Medical Sciences Central Arkansas Veteran s Healthcare System
More informationPrimary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group
Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to
More informationManagement of Lipid Disorders and Hypertension: Implications of the New Guidelines
Management of Lipid Disorders and Hypertension Management of Lipid Disorders and Hypertension: Implications of the New Guidelines Robert B. Baron MD MS Professor and Associate Dean UCSF School of Medicine
More informationMANAGEMENT OF HYPERTENSION IN EGYPT AND DEVELOPING COUNTRIES
EGYPTIAN HYPERTENSION SOCIETY GUIDELINES MANAGEMENT OF HYPERTENSION IN EGYPT AND DEVELOPING COUNTRIES 2003 EXECUTIVE SUMMARY PREPARED BY M. MOHSEN IBRAHIM, MD PROFESSOR OF CARDIOLOGY- CAIRO UNIVERSITY
More informationhypertension Head of prevention and control of CVD disease office Ministry of heath
hypertension t. Samavat MD,Cadiologist,MPH Head of prevention and control of CVD disease office Ministry of heath RECOMMENDATIONS FOR HYPERTENSION DIAGNOSIS, ASSESSMENT, AND TREATMENT Definition of hypertension
More informationWe are delighted to have Dr. Roetzheim with us today to discuss Managing Hypertension in Older Adult Patients.
Richard Roetzheim, MD, MSPH is Professor and Chair, Department of Family Medicine at the University of South Florida Morsani College of Medicine. Dr. Roetzheim has considerable experience leading NIH funded
More informationMi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series
Our speaker today is: Susan Vos, BSN, RN, CCM Mi-CCSI welcomes you to the 2 nd in our 4 part Basics of Disease Management Webinar Series We will be starting shortly A few housekeeping items: We will be
More informationT. Suithichaiyakul Cardiomed Chula
T. Suithichaiyakul Cardiomed Chula The cardiovascular (CV) continuum: role of risk factors Endothelial Dysfunction Atherosclerosis and left ventricular hypertrophy Myocardial infarction & stroke Endothelial
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationAntihypertensive Trial Design ALLHAT
1 U.S. Department of Health and Human Services Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic National Institutes
More informationUpdate on Current Trends in Hypertension Management
Friday General Session Update on Current Trends in Hypertension Management Shawna Nesbitt, MD Associate Dean, Minority Student Affairs Associate Professor, Department of Internal Medicine Office of Student
More informationInt. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences
Research Article JNC 8 versus JNC 7 Understanding the Evidences Anns Clara Joseph, Karthik MS, Sivasakthi R, Venkatanarayanan R, Sam Johnson Udaya Chander J* RVS College of Pharmaceutical Sciences, Coimbatore,
More informationThe Latest Generation of Clinical
The Latest Generation of Clinical Guidelines: HTN and HLD Dave Brackett Clinical Guideline Purpose Uniform approach Awareness of key details Diagnosis Treatment Monitoring Evidence based approach Inform
More informationTreating Hypertension in Individuals with Diabetes
Treating Hypertension in Individuals with Diabetes Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form or by any
More information2014 HYPERTENSION GUIDELINES
2014 HYPERTENSION GUIDELINES Eileen M. Twomey, Pharm.D., BCPS 1 Learning Objectives Describe specific blood pressure thresholds at which antihypertensive therapy should be initiated and blood pressure
More informationClinical Recommendations: Patients with Periodontitis
The American Journal of Cardiology and Journal of Periodontology Editors' Consensus: Periodontitis and Atherosclerotic Cardiovascular Disease. Friedewald VE, Kornman KS, Beck JD, et al. J Periodontol 2009;
More informationNew Hypertension Guidelines. Kofi Osei, MD
New Hypertension Guidelines Kofi Osei, MD None Disclosures Objectives The new blood pressure definitions and cardiovascular risk The role to time and location in the diagnosis of hypertension Apply evidence-based
More informationKey Elements in Managing Diabetes
Key Elements in Managing Diabetes Presentor Disclosure No conflicts of interest to disclose Presented by Susan Cotey, RN, CDE Lennon Diabetes Center Stephanie Tubbs Jones Health Center Cleveland Clinic
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS ONLY. MEASURE TYPE: Process
Quality ID #317: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented National Quality Strategy Domain: Community / Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:
More informationDiagnosis and treatment of hypertension. Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington
Diagnosis and treatment of hypertension Kari Nelson, MD MSHS Division of General Internal Medicine VA Puget Sound, University of Washington Outline Epidemiology Diagnosis Evaluation of individuals with
More informationSponsored by the National Heart, Lung, and Blood Institute (NHLBI)
1 U.S. Department of Health and Human Services The Hypertension, Detection, and Follow-up Program (HDFP) The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) National
More information